In the same issue where the NN101 SMA primary results were published, the Annals of Neurology also published an accompanying editorial with high praise for the Network. The authors noted that “NeuroNEXT is clearly trying to change the landscape of clinical trials in neurology, helping to empower the academic investigator to pursue research efforts that would otherwise be impossible.”
Editorial accompanying NN101 primary manuscript compliments NeuroNEXT network
External Source: Annals of Neurology, Vol. 82, No. 6